Medications for Hypercholesterolemia

6 results
  • leqvio - inclisiran injection, solution

    (Inclisiran)
    Novartis Pharmaceuticals Corporation
    Leqvio is used with diet and exercise to lower LDL cholesterol in adults with hypercholesterolemia, and in adults and patients aged 12 and older with heterozygous or homozygous familial hypercholesterolemia.
  • nexletol - bempedoic acid tablet, film coated

    (Bempedoic Acid)
    Esperion Therapeutics, Inc.
    Nexletol reduces the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults unable to take statins, and lowers LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, alone or with other cholesterol-lowering therapies.
  • nexlizet - bempedoic acid and ezetimibe tablet, film coated

    (Bempedoic Acid And Ezetimibe)
    Esperion Therapeutics, Inc.
    Nexlizet (bempedoic acid/ezetimibe) reduces LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, as an adjunct to diet and exercise. It also lowers the risk of cardiovascular death, heart attack, stroke, or coronary revascularization in adults at increased risk who cannot take recommended statin therapy.
  • praluent - alirocumab injection, solution

    (Alirocumab)
    Regeneron Pharmaceuticals, Inc.
    Praluent reduces LDL cholesterol in adults with hypercholesterolemia, HeFH, or HoFH (ages 8+), and lowers the risk of major cardiovascular events—heart attack, stroke, coronary death, or unstable angina—in high-risk adults.
  • repatha - evolocumab injection, solution

    (Evolocumab)
    Amgen Usa Inc.
    Repatha reduces the risk of major cardiovascular events (CV death, heart attack, stroke) in high-risk adults, and lowers LDL cholesterol in adults with hypercholesterolemia and patients aged 10+ with heterozygous or homozygous familial hypercholesterolemia, as an adjunct to diet and exercise.